Stephanie Hallisey1, Reeva Makhijani1, Jeffrey Thorne2, Prachi Godiwala1, John Nulsen1, Claudio Benadiva1, Daniel Grow1, Lawrence Engmann3. 1. Center for Advanced Reproductive Services, Division of Reproductive Endocrinology & Infertility, University of Connecticut Health Center, 2 Batterson Park Rd, Farmington, CT, 06032, USA. 2. Reproductive Medicine Associates of Philadelphia, 1015 Chestnut Street, 8th Floor, Philadelphia, PA, 19107, USA. 3. Center for Advanced Reproductive Services, Division of Reproductive Endocrinology & Infertility, University of Connecticut Health Center, 2 Batterson Park Rd, Farmington, CT, 06032, USA. lengmann@uchc.edu.
Abstract
PURPOSE: The purpose of this study was to determine the impact of body mass index (BMI) on euploidy rates for in vitro fertilization (IVF) cycles with preimplantation genetic testing (PGT) utilizing primarily next-generation sequencing (NGS). METHODS: This retrospective cohort study included women aged ≤ 45 years who underwent IVF/PGT between September 2013 and September 2020 at a single university-affiliated fertility center. The primary outcome was euploidy rate. Secondary outcomes included peak serum estradiol (E2), number of oocytes retrieved, oocyte maturation rate, high-quality blastulation rate, clinical loss rate (CLR), clinical pregnancy rate (CPR), and ongoing pregnancy/live birth rate (OPR/LBR). RESULTS: The study included 1335 IVF cycles that were stratified according to BMI (normal, n = 648; overweight, n = 377; obese, n = 310). The obese group was significantly older with significantly lower baseline FSH, peak E2, high-quality blastulation rate, and number of embryos biopsied than the normal group. Overall euploidy rates were not significantly different between BMI groups (normal 36.4% ± 1.3; overweight 37.3% ± 1.8; obese 32.3% ± 1.8; p = 0.11), which persisted after controlling for covariates (p = 0.82) and after stratification of euploidy rate by age group and by number of oocytes retrieved per age group. There were no significant differences in CLR, CPR, and OPR/LBR across BMI groups. CONCLUSIONS: Despite a lower high quality blastulation rate with obesity, there is not a significant difference in euploidy rates across BMI groups in women undergoing IVF/PGT.
PURPOSE: The purpose of this study was to determine the impact of body mass index (BMI) on euploidy rates for in vitro fertilization (IVF) cycles with preimplantation genetic testing (PGT) utilizing primarily next-generation sequencing (NGS). METHODS: This retrospective cohort study included women aged ≤ 45 years who underwent IVF/PGT between September 2013 and September 2020 at a single university-affiliated fertility center. The primary outcome was euploidy rate. Secondary outcomes included peak serum estradiol (E2), number of oocytes retrieved, oocyte maturation rate, high-quality blastulation rate, clinical loss rate (CLR), clinical pregnancy rate (CPR), and ongoing pregnancy/live birth rate (OPR/LBR). RESULTS: The study included 1335 IVF cycles that were stratified according to BMI (normal, n = 648; overweight, n = 377; obese, n = 310). The obese group was significantly older with significantly lower baseline FSH, peak E2, high-quality blastulation rate, and number of embryos biopsied than the normal group. Overall euploidy rates were not significantly different between BMI groups (normal 36.4% ± 1.3; overweight 37.3% ± 1.8; obese 32.3% ± 1.8; p = 0.11), which persisted after controlling for covariates (p = 0.82) and after stratification of euploidy rate by age group and by number of oocytes retrieved per age group. There were no significant differences in CLR, CPR, and OPR/LBR across BMI groups. CONCLUSIONS: Despite a lower high quality blastulation rate with obesity, there is not a significant difference in euploidy rates across BMI groups in women undergoing IVF/PGT.
Authors: George A Bray; William E Heisel; Ashkan Afshin; Michael D Jensen; William H Dietz; Michael Long; Robert F Kushner; Stephen R Daniels; Thomas A Wadden; Adam G Tsai; Frank B Hu; John M Jakicic; Donna H Ryan; Bruce M Wolfe; Thomas H Inge Journal: Endocr Rev Date: 2018-04-01 Impact factor: 19.871
Authors: Joshua L Weiss; Fergal D Malone; Danielle Emig; Robert H Ball; David A Nyberg; Christine H Comstock; George Saade; Keith Eddleman; Suzanne M Carter; Sabrina D Craigo; Stephen R Carr; Mary E D'Alton Journal: Am J Obstet Gynecol Date: 2004-04 Impact factor: 8.661
Authors: Margaret L Watkins; Sonja A Rasmussen; Margaret A Honein; Lorenzo D Botto; Cynthia A Moore Journal: Pediatrics Date: 2003-05 Impact factor: 7.124
Authors: Jan Willem van der Steeg; Pieternel Steures; Marinus J C Eijkemans; J Dik F Habbema; Peter G A Hompes; Jan M Burggraaff; G Jur E Oosterhuis; Patrick M M Bossuyt; Fulco van der Veen; Ben W J Mol Journal: Hum Reprod Date: 2007-12-11 Impact factor: 6.918
Authors: Meredith P Provost; Kelly S Acharya; Chaitanya R Acharya; Jason S Yeh; Ryan G Steward; Jennifer L Eaton; James M Goldfarb; Suheil J Muasher Journal: Fertil Steril Date: 2015-10-30 Impact factor: 7.329
Authors: Annemarie G M G J Mulders; Joop S E Laven; Marinus J C Eijkemans; Edward G Hughes; Bart C J M Fauser Journal: Hum Reprod Update Date: 2003 Sep-Oct Impact factor: 15.610